UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
This article examines Why Do Stablecoins Fail, focusing on reserve adequacy, liquidity mismanagement, and governance gaps that threaten peg stability.
17,822 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Ethereum isn't resting on its laurels. A bold plan for 2029 aims to streamline the network, cut costs, and attract bu...
Home Depot's Q1 2026 results provide a window into consumer demand, mix shifts, and profitability. This article break...
Thai and Taiwanese AI stock funds are gaining traction as Korea’s AI boom extends across Asia. This report examines w...
Today’s stock market activity shows SoFi (SOFI) directing attention as investors weigh inflation signals and higher y...
Sen. JD Vance faulted the Trump administration's handling of Epstein-related documents, calling out missteps in commu...
Truth Social’s spot Bitcoin ETF has withdrawn its S-1 filing, signaling tougher market conditions for plain-vanilla c...
The latest Trustees report reveals a $160.2 billion gap for 2025, forcing reserve use and signaling looming benefit p...
Boeing stands at greater risk than peers if Elon Musk's Tesla and SpaceX ever join forces, a scenario analysts say co...
Amazon's cloud unit, AWS, stands as a pillar of the company's profitability. This article breaks down the cloud growt...
AI-driven capital spending is accelerating demand for etching and related fabrication equipment, spotlighting semicon...
Cardano’s Van Rossem hard fork is set to activate tomorrow, amid a surge in whale buying and rising open interest. Tr...